Product NDC: | 0409-1626 |
Proprietary Name: | Butorphanol Tartrate |
Non Proprietary Name: | Butorphanol Tartrate |
Active Ingredient(s): | 2 mg/mL & nbsp; Butorphanol Tartrate |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-1626 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074626 |
Marketing Category: | ANDA |
Start Marketing Date: | 19970123 |
Package NDC: | 0409-1626-01 |
Package Description: | 3 CONTAINER in 1 CASE (0409-1626-01) > 10 VIAL, SINGLE-DOSE in 1 CONTAINER > 1 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 0409-1626-01 |
Proprietary Name | Butorphanol Tartrate |
Package Description | 3 CONTAINER in 1 CASE (0409-1626-01) > 10 VIAL, SINGLE-DOSE in 1 CONTAINER > 1 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 0409-1626 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Butorphanol Tartrate |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 19970123 |
Marketing Category Name | ANDA |
Labeler Name | Hospira, Inc. |
Substance Name | BUTORPHANOL TARTRATE |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Competitive Opioid Antagonists [MoA],Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA] |